On 04/09/2012 09:33 AM, Simon Phipps wrote:
On 9 Apr 2012, at 14:31, Robert Ryley wrote:
I figured list members might be pleased to know about this.
I am a member of the AMWA (American Medical Writers Association) and
contributor to their Technology section. I was able to get a 150 word
article placed on LibreOffice before a large audience of professional
writers in the pharmaceutical, medical, and health sector. I may have
the opportunity to write a longer, feature article and plan on
covering LibreOffice sometime later this year.
That's excellent, thanks for letting us know. If you find a URL pointing to it be sure to say as
several of us like to post links about LibreOffice on Twitter, Facebook and Google+.
Cheers,
S.
It would be great to have any group of professionals get the word that
there is an alternative to MS Office and their big fees.
It would be hard for someone like me to write up something "informative"
about the benefits of LibreOffice to a group of professionals that is
150 words of less. Some can, but for me there are so many things I
would want to cover. The last bit being that LO is free where MSO costs
$100 or more every time they want you to upgrade to their newest version.
--
Unsubscribe instructions: E-mail to marketing+help@global.libreoffice.org
Problems? http://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more: http://wiki.documentfoundation.org/Netiquette
List archive: http://listarchives.libreoffice.org/global/marketing/
All messages sent to this list will be publicly archived and cannot be deleted
Context
Privacy Policy |
Impressum (Legal Info) |
Copyright information: Unless otherwise specified, all text and images
on this website are licensed under the
Creative Commons Attribution-Share Alike 3.0 License.
This does not include the source code of LibreOffice, which is
licensed under the Mozilla Public License (
MPLv2).
"LibreOffice" and "The Document Foundation" are
registered trademarks of their corresponding registered owners or are
in actual use as trademarks in one or more countries. Their respective
logos and icons are also subject to international copyright laws. Use
thereof is explained in our
trademark policy.